| Leptomeningeal Neoplasm studied in …STUDIED_INderived32 of 32show fewer |
|---|
| → studied in | NCT05809752Phase 1 · active not recruiting A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04988009recruiting Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology · condition mapped ONTOLOGY_EXACT · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07814352Phase 1 · recruiting A Study of SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07390539Phase 1 · recruiting B7-H3.CD28Z.CART in CNS Neoplasms · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03025256Phase 1 · active not recruiting Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease · condition mapped ONTOLOGY_EXACT · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07414979Phase 1 · not yet recruiting Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Meningeal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07751744Phase 1/Phase 2 · not yet recruiting Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07476781NA · recruiting Exploring the Feasibility of Cerebrospinal Fluid (CSF) and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and Primary Central Nervous System (CNS) Tumours: A Pilot Study · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03423628Phase 1 · active not recruiting A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07694986Phase 2 · recruiting Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07689721NA · not yet recruiting ctDNA-Guided Intraventricular Therapy for CNS Malignancies · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02422641Phase 2 · recruiting Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03175432Phase 2 · active not recruiting Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases · condition mapped ONTOLOGY_EXACT · 32 trials mapped (22 active) | — | — | Intracranial Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07415018NA · recruiting Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04250545Phase 1 · active not recruiting Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04588545Phase 1/Phase 2 · active not recruiting Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06146010recruiting Non Interventional German Leptomeningeal Disease Register · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03719768Phase 1 · completed Avelumab With Radiotherapy in Patients With Leptomeningeal Disease · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05305365Phase 2 · active not recruiting Study Assessing QBS72S For Treating Brain Metastases · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05800275Phase 2 · recruiting Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03501979Phase 2 · terminated Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06926803active not recruiting A Clinical Study of Furmonertinib in the Treatment of EGFR-Mutated NSCLC With Leptomeningeal Metastases · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Malignant Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05112549Phase 1 · recruiting Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26) · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06417710recruiting Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05414123terminated A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05984108unknown Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System · condition mapped ONTOLOGY_EXACT · 32 trials mapped (22 active) | — | — | Meningeal Melanocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03711422Phase 1 · terminated Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02194452NA · withdrawn Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors · condition mapped ONTOLOGY_EXACT · 32 trials mapped (22 active) | — | — | Meningeal Melanocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02967380NA · terminated Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Adult Central Nervous System Melanocytic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01119599Phase 1 · completed RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma · condition mapped ALIAS · 32 trials mapped (22 active) | — | — | Adult Central Nervous System Melanocytic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492089Phase 2 · completed Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 32 trials mapped (22 active) | — | — | Meningeal Melanocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00110032Phase 1 · terminated Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors · condition mapped ONTOLOGY_EXACT · 32 trials mapped (22 active) | — | — | Meningeal Melanocytoma | 1 | Observed | clinicaltrials | graph → |